I agree that this site is using cookies. You can find further informations here.
X
Vilarrasa, Eva
77  results:
Search for persons X
?
1

Real‐world effectiveness and safety of bimekizumab for hidr..:

Mansilla‐Polo, Miguel ; Pons‐Benavent, Martí ; Fernández‐Crehuet, Pablo...
Australasian Journal of Dermatology.  , 2024
Link: https://doi.org/10.1111/..
 
?
2

Treatment of Psoriasis Patients with Latent Tuberculosis Us..:

Torres, Tiago ; Chiricozzi, Andrea ; Puig, Luis...
American Journal of Clinical Dermatology.  25 (2024)  2 - p. 333-342 , 2024
Link: https://doi.org/10.1007/..
 
?
3

Drainage setons for the management of sinus tracts in hidra..:

Vilarrasa, Eva ; Camiña-Conforto, Gemma ; Cabo, Fernando...
Journal of the American Academy of Dermatology.  90 (2024)  5 - p. e157-e158 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Management of hidradenitis suppurativa tunnels using draina..:

Fernández-Vela, Javier ; Romaní, Jorge ; Cabo, Fernando...
Journal of the American Academy of Dermatology.  90 (2024)  4 - p. 868-870 , 2024
Link: https://doi.org/10.1016/..
 
?
5

Mohs micrographic surgery in immunosuppressed vs immunocomp..:

Abril‐Pérez, Carlos ; Mansilla‐Polo, Miguel ; Escutia‐Muñoz, Begoña...
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
6

Real‐world adalimumab survival and discontinuation factors ..:

Garbayo‐Salmons, Patricia ; Vilarrasa, Eva ; Bassas‐Vila, Julio...
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
7

Ustekinumab is effective and safe in the long‐term treatmen..:

Plana, Clara ; Concha‐Garzón, Maria J. ; Rocamora, Vicen C....
JEADV Clinical Practice.  3 (2024)  2 - p. 604-610 , 2024
Link: https://doi.org/10.1002/..
 
?
8

Response letter to "Tracing the origins of setons in hidrad..:

Camiña-Conforto, Gemma ; Vilarrasa, Eva ; Cabo, Fernando...
Journal of the American Academy of Dermatology.  90 (2024)  4 - p. e141-e142 , 2024
Link: https://doi.org/10.1016/..
 
?
9

Age affects drug survival rates of interleukin (IL)‐17 and ..:

Chiricozzi, Andrea ; Coscarella, Giulia ; Puig, Luis...
Journal of the European Academy of Dermatology and Venereology.  , 2024
Link: https://doi.org/10.1111/..
 
?
10

Dose reduction is a feasible strategy in patients with plaq..:

Daudén, Esteban ; Escario, Elena ; Martos‐Cabrera, Luisa...
International Journal of Dermatology.  63 (2024)  4 - p. 503-511 , 2024
Link: https://doi.org/10.1111/..
 
?
11

The Essential Role of IL-17 as the Pathogenetic Link betwee..:

Olveira, Antonio ; Augustin, Salvador ; Benlloch, Salvador...
Life.  13 (2023)  2 - p. 419 , 2023
Link: https://doi.org/10.3390/..
 
?
12

No tuberculosis reactivations in psoriasis patients initiat..:

Manzanares, Nerea ; Vilarrasa, Eva ; López, Anna...
Journal of the European Academy of Dermatology and Venereology.  38 (2023)  1 - p. , 2023
Link: https://doi.org/10.1111/..
 
?
13

Development and validation of a model to predict complex Mo..:

Montero‐Vilchez, Trinidad ; Garcés, Joan R. ; Rodríguez‐Prieto, Manuel A....
Journal of the European Academy of Dermatology and Venereology.  37 (2023)  8 - p. 1587-1594 , 2023
Link: https://doi.org/10.1111/..
 
?
14

Unmet clinical needs, burden of disease and treatment patte..:

Vilarrasa, Eva ; Molina‐Leyva, Alejandro ; Martín, Víctor...
JEADV Clinical Practice.  3 (2023)  1 - p. 347-357 , 2023
Link: https://doi.org/10.1002/..
 
?
15

Reply to: "Comment on 'Interruption of oral clindamycin plu..:

Schneller-Pavelescu, Luca ; Vergara-de Caso, Eduardo ; Martorell, Antonio...
Journal of the American Academy of Dermatology.  88 (2023)  5 - p. e271-e272 , 2023
Link: https://doi.org/10.1016/..
 
1-15